Renal distribution of Vasohibin-1 in patients with chronic kidney disease.

Renal distribution of Vasohibin-1 in patients with chronic kidney disease.
复制标题

DOI:
10.18926/amo/52788
复制
发表时间:
2014-06
影响因子:
0.5
通讯作者:
Norikazu Hinamoto;Y. Maeshima;D. Saito;H. Yamasaki;Katsuyuki Tanabe;Tatsuyo Nasu;H. Watatani;H. Ujike;M. Kinomura;H. Sugiyama;H. Sonoda;N. Kanomata;Yasufumi Sato;H. Makino
Norikazu Hinamoto;Y. Maeshima;D. Saito;H. Yamasaki;Katsuyuki Tanabe;Tatsuyo Nasu;H. Watatani;H. Ujike;M. Kinomura;H. Sugiyama;H. Sonoda;N. Kanomata;Yasufumi Sato;H. Makino
中科院分区:
医学4区
文献类型:
--
作者:
Norikazu Hinamoto;Y. Maeshima;D. Saito;H. Yamasaki;Katsuyuki Tanabe;Tatsuyo Nasu;H. Watatani;H. Ujike;M. Kinomura;H. Sugiyama;H. Sonoda;N. Kanomata;Yasufumi Sato;H. Makino

文献摘要

相似文献

实验研究已经证明血管生成相关因子参与慢性肾脏疾病(CKD)的进展。血管生成负反馈调节因子Vasohibin-1(VASH-1)在CKD中的分布及临床作用尚未见报道。我们招募了54名日本CKD患者和6名因局限性肾细胞癌切除正常肾组织的患者。我们评估了肾脏VASH-1表达水平与临床/组织学参数之间的相关性。VASH-1在肾内皮/系膜细胞、新月体病变和间质炎性细胞中观察到。新月体形成与肾小球内VASH-1+细胞数呈显著正相关(r = 0.48,p = 0.001)或皮质(r = 0.64,p <0.0001),2)皮质中间质细胞浸润和VASH-1+细胞数量(3)肾小球VEGFR-2+细胞面积与VASH-1+细胞数(肾小球r = 0.44,p = 0.01)或髓质r = 0.63,p = 0.01)。这些结果表明,VASH-1的肾脏水平可能受到局部炎症,新月体病变和VEGFR-2的影响。
Experimental studies have demonstrated the involvement of angiogenesis-related factors in the progression of chronic kidney disease (CKD). There have so far been no reports investigating the distribution and clinical roles of Vasohibin-1 (VASH-1), a negative feedback regulator of angiogenesis, in CKD. We recruited 54 Japanese CKD patients and 6 patients who had normal renal tissues excised due to localized renal cell carcinoma. We evaluated the correlations between the renal expression level of VASH-1 and the clinical/histological parameters. VASH-1 was observed in renal endothelial/mesangial cells, crescentic lesions and interstitial inflammatory cells. Significant positive correlations were observed between 1) crescent formation and the number of VASH-1+ cells in the glomerulus (r=0.48, p=0.001) or cortex (r=0.64, p<0.0001), 2) interstitial cell infiltration and the number of VASH-1+ cells in the cortex (r=0.34, p=0.02), 3) the glomerular VEGFR-2+ area and the number of VASH-1+ cells in the glomerulus (r=0.44, p=0.01) or medulla (r=0.63, p=0.01). These results suggest that the renal levels of VASH-1 may be affected by local inflammation, crescentic lesions and VEGFR-2.